Status:
COMPLETED
A Comparative Study Between Postextubation of Preterm Infants Into High-Flow Nasal Cannulae V.S Nasal Continuous Positive Airway Pressure
Lead Sponsor:
Ramy Saleh Morsy
Conditions:
Neonatal Respiratory Distress
Eligibility:
All Genders
1-28 years
Brief Summary
The investigators hypothesize that there is a growing trend of the feasibility of HFNC as an alternative to other forms of non-invasive ventilation mechanism to provide continuous distending pressure ...
Detailed Description
Our primary outcome is to determine whether postextubation respiratory support via heated humidified high-flow nasal cannula results in a greater proportion of infants younger than 34 weeks gestation ...
Eligibility Criteria
Inclusion
- •Infants born at a gestational age of less than 34 weeks, receiving mechanical ventilation through an endotracheal tube.
Exclusion
- Full term neonates or large for gestational age.
- Preterm neonates not supported primarily by invasive ventilation.
- Infants with suspected upper airway obstruction, congenital airway malformations or major cardiopulmonary malformations.
Key Trial Info
Start Date :
June 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04051762
Start Date
June 1 2017
End Date
July 30 2018
Last Update
August 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Magda Mahmoud Badawy
Cairo, Egypt